Skip to Content
Merck
  • Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

The Journal of biological chemistry (2013-11-13)
Tracey B Tucker Zhou, Gwendalyn D King, CiDi Chen, Carmela R Abraham
ABSTRACT

Klotho (KL) is an age-regulating protein named after the Greek goddess who spins the thread of life. Mice deficient in KL are normal throughout development, but rapidly degenerate and display a variety of aging-associated abnormalities that eventually lead to decreased life expectancy. While multiple genetic association studies have identified KL polymorphisms linked with changes in disease risk, there is a paucity of concrete mechanistic data to explain how these amino acid substitutions alter KL protein function. The KLVS polymorphism is suggested to lead to changes in protein trafficking although the mechanism is unclear. Our studies have sought to further investigate the functional differences in the KLVS variant that result in increased risk of many age-related diseases. Our findings suggest that the F352V and C370S substitutions lead to alterations in processing as seen by differences in shedding and half-life. Their co-expression in KLVS results in a phenotype resembling wild-type, but despite this intragenic complementation there are still changes in homodimerization and interactions with FGFR1c. Taken together, these studies suggest that KLVS leads to altered homodimerization that indirectly leads to changes in processing and FGFR1c interactions. These findings help elucidate the functional differences that result from the VS polymorphism, which will help clarify how alterations in KL function can lead to human disease and affect cognition and lifespan.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type H-2, aqueous solution, ≥85,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type H-3AF, aqueous solution, ≥60,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type HP-2S, aqueous solution, ≥90,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type HP-2, aqueous solution, ≥100,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type H-5, lyophilized powder, ≥400,000 units/g solid
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type H-3, aqueous solution, ≥90,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Helix pomatia, Type H-1, partially purified powder, ≥300,000 units/g solid
Sigma-Aldrich
β-Glucuronidase from limpets (Patella vulgata), Type L-II, lyophilized powder, 1,000,000-3,000,000 units/g solid
Sigma-Aldrich
β-Glucuronidase from limpets (Patella vulgata), aqueous solution, ≥85,000 units/mL
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, ≥20,000 units/mg protein, recombinant, expressed in E. coli overproducing strain, lyophilized powder
Sigma-Aldrich
β-Glucuronidase from Helix aspersa (garden snail), Type HA-4
Sigma-Aldrich
β-Glucuronidase from bovine liver, Type B-3, ≥2,000,000 units/g solid
Sigma-Aldrich
β-Glucuronidase from bovine liver, Type B-1, ≥1,000,000 units/g solid
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, aqueous glycerol solution, ≥5,000,000 units/g protein, pH 6.8 (biuret)
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, Type VII-A, lyophilized powder, 5,000,000-20,000,000 units/g protein, pH 6.8 (30 min assay)
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, Type IX-A, lyophilized powder, 1,000,000-5,000,000 units/g protein (30 min assay)
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, >20,000,000 units/g protein, recombinant, expressed in E. coli, aqueous glycerol solution
Sigma-Aldrich
β-Glucuronidase from Escherichia coli, ≥10,000,000 units/g protein (30 min assay), recombinant, expressed in E. coli overproducing strain, lyophilized powder